3C Patch System for treating hard-to-heal diabetic foot ulcers that have not responded to treatment with advanced dressings. 3C Patch is a ready-to-use biological patch made on-site from a person's own blood, which forms a matrix of fibrin, leukocytes and platelets.
 
Status In progress
Process MT
ID number 539

Provisional Schedule

Committee meeting: 1 (draft guidance) 18 June 2021
Draft guidance 13 July 2021 - 10 August 2021
Committee meeting: 2 (final guidance) 15 October 2021
Resolution 22 November 2021
Expected publication 19 January 2022

Project Team

Project lead Rebecca Brookfield

Email enquiries

Stakeholders

External assessment group KiTEC
Manufacturers Reapplix
Patient carer organisations British Skin Foundation (BSF)
  Leg Ulcer Charity
  Pressure Ulcers UK
  Leonard Cheshire disability
  Diabetes UK
  Foot in Diabetes UK
  MRSA Action UK
  The Lindsay Leg Club Foundation
  Juvenile Diabetes Research Foundation
  Diabetes Research & Wellness Foundation
  InDependent Diabetes Trust
  Limbless Association
  The Circulation Foundation
Professional groups Association of British Clinical Diabetologists
  Royal College of Physicians
  Royal College of Nursing
  Tissue Viability Society
  Vascular Society of Great Britain & Ireland
  Society of Chiropodists and Podiatrists
  Primary Care Diabetes Society
  Society of Vascular Nurses
  Institute of Chiropodists and Podiatrists
  The College of Podiatry
  Royal College of Surgeons
  British Society for Paediatric Endocrinology and Diabetes
  The Welsh Wound Innovation Initiative

Timeline

Key events during the development of the guidance:

Date Update
05 March 2021 Scope published

For further information on how we develop guidance, please see our page about NICE medical technologies guidance